Sanofi and GSK close to reaching $624 Million U.K. Vaccine Deal
Sanofi and GlaxoSmithKline are close to reaching a 500 million-pound ($624 million) deal to supply the United Kingdom government with
Read more
Drug Development
New high CBD cannabis sativa could be effective against SARS-CoV2
Recent Canada-based research studies on cannabis sativa extract with high CBD content are demonstrating encouraging outcomes, such as inhibiting the
Read more
AbbVie and BioMed to develop monoclonal antibody for COVID-19
AbbVie, Harbour BioMed, Utrecht University and the Erasmus Medical Center (EMC) revealed today they have entered into a partnership to
Read more
Preventative approaches and treatment options for COVID-19
Researchers across the world are racing to develop preventative approaches and treatment options for COVID-19, including monoclonal antibodies, vaccines and
Read more
Vault Pharma designing new Vault-based Coronavirus Vaccine
Vault Pharma is collaborating with UCLA and other universities to develop a coronavirus vaccine with the capacity to treat the
Read more
Sunovion gets FDA nod for KYNMOBI™ as Parkinson’s Disease treatment
Sunovion has announced it has received approval from the FDA for KYNMOBI™ (apomorphine hydrochloride) Sublingual Film for the treatment of
Read more
New Medicine may stop COVID-19 Pandemic ‘Without Vaccination’
A Chinese laboratory has been creating a new antibody medicine considered to have the potential to cease the coronavirus pandemic,
Read more
AstraZeneca to advance Oxford’s COVID-19 vaccine with $1bn investment
AstraZeneca is going to expedite the development of the University of Oxford investigational COVID-19 vaccine with a $1 billion BARDA
Read more
Pfizer’s gene therapy promising for Duchenne muscular dystrophy (DMD)
Pfizer Inc. has revealed revised clinical Phase 1b results on PF-06939926, an investigational gene therapy to treat Duchenne muscular dystrophy
Read more
CEPI to fund Novavax COVID-19 vaccine with up to $388 Million
CEPI has increased its investment with up to $388 million for the Novavax COVID-19 (NVX‑CoV2373) vaccine development and manufacturing. Phase
Read more